Pomegranate demonstrates the capacity to significantly aid in cancer treatment. Specifically, the consumption of pomegranate seed extract, juice, and oil has yielded promising outcomes for breast, colon, and prostate cancers.*
A global team of researchers, in a recent review article, delved into the potential influence of pomegranate on these particular cancers. Their findings were subsequently published in the journal Phytotherapy Research.
Prior investigations have already indicated that metabolites derived from pomegranate can contribute to combating colon cancer. It is not coincidental that these exotic fruits are regarded as one of horticultural species exhibiting considerable therapeutic promise against cancer.
For centuries, pomegranate has been utilized as a medicinal plant. In recent years, it has also gained traction as a dietary supplement in cancer therapy, as clarified by the researchers.
Currently, experts have assessed the therapeutic potential of pomegranate seed extract, juice, and oil in addressing breast cancer, colorectal cancer, and prostate cancer by conducting a comprehensive review of existing studies.
The research group reports that the intake of pomegranate-derived products is associated with several beneficial effects in these cancer types. Consequently, pomegranate could offer an exceptionally valuable complementary contribution to cancer therapies.
Nevertheless, the researchers note that it remains largely unclarified what specific chemical compounds are responsible for these effects. They express hope that the outcomes of this review will also provide a foundation for future research aimed at identifying the compounds (or their metabolites) responsible for pomegranate’s anti-cancer properties.
About the Author
